Collagen is the most abundant structural protein in the human body. It provides structural support to skin, joints, and connective tissues and plays an important role in maintaining skin strength, elasticity, and overall structural integrity. Collagen production naturally declines with age, which can influence skin firmness and elasticity over time.

QYRA contains VERISOL® bioactive collagen peptides, which are designed to deliver specific peptide structures associated with skin health.
After ingestion, certain collagen peptides can be absorbed through the digestive system and transported through the bloodstream to connective tissues such as the dermis layer of the skin.

Research indicates that these peptides may interact with fibroblast cells involved in the
production of collagen, elastin, and hyaluronic acid.

QYRA contains bovine-derived collagen peptides and may not be suitable for:

• Individuals with allergies to bovine products
• Individuals following vegetarian or vegan diets
  

Pregnant or breastfeeding women, individuals with medical conditions, or those taking prescription medications should consult a healthcare professional before use.

QYRA is intended for adult use only (18+).

VERISOL® is a patented bioactive collagen peptide ingredient developed by Gelita AG in Germany, one of the world’s most established collagen manufacturers with over 140 years of collagen research and production expertise.

It is produced from bovine collagen through controlled enzymatic hydrolysis, resulting in targeted peptide structures with defined molecular characteristics. VERISOL is manufactured in Gelita’s German production facilities, where research, peptide development, quality control, and manufacturing are vertically integrated within the same organization. This integrated approach allows R&D, formulation science, and manufacturing to be controlled under one system by a specialized collagen manufacturer.

Many collagen supplements contain generic hydrolyzed collagen, which is produced by breaking down collagen protein into a broad mixture of amino acids and peptides.

These hydrolyzed collagen powders typically contain peptides of varying sizes and structures, and the specific peptide composition is often not defined.

QYRA contains VERISOL® bioactive collagen peptides, which are produced through controlled enzymatic processes that generate specific peptide structures with an average molecular weight of approximately 2000 Daltons. VERISOL peptides have been evaluated in human clinical studies measuring parameters such as:

• Skin elasticity
• Wrinkle appearance
• Dermal collagen structure
• Cellulite appearance

This means the collagen ingredient used in QYRA is scientifically characterized and clinically evaluated, rather than being a general hydrolyzed collagen blend.

QYRA® Collagen Drink can be taken once daily at any time, based on your routine. Many users prefer taking it in the morning or alongside a meal for consistency. Regular daily intake is key to supporting skin elasticity and overall skin health.

Many collagen supplements use generic hydrolyzed collagen, which functions primarily as a collagen protein source.

Because of this, larger servings such as 10–15 grams per day are often recommended.

VERISOL peptides, however, have been evaluated in human clinical studies using 2.5 grams per day, measuring changes in skin elasticity and wrinkle appearance.

Rather than relying on large quantities of collagen protein, QYRA provides bioactive peptides studied at a defined daily intake.

Human clinical studies evaluating VERISOL peptides observed measurable improvements in skin parameters such as elasticity and wrinkle appearance after approximately 8–12 weeks of daily supplementation. These findings were reported in controlled human studies including:

• Proksch et al., Skin Pharmacology and Physiology (2014) – a randomized, double-blind clinical study conducted at dermatological research institutions in Kiel, Germany, reporting improvements in skin elasticity following daily supplementation with VERISOL collagen peptides.
  
• Proksch et al., Journal of Medical Nutrition & Nutraceuticals (2014) – a controlled clinical investigation conducted with dermatology research groups in Germany, observing reductions in wrinkle volume and improvements in dermal skin structure after collagen peptide supplementation.
  
• Schunck et al., Clinical, Cosmetic and Investigational Dermatology (2015) – a randomized controlled trial conducted at European dermatology research centers, reporting improvements in cellulite appearance following sustained collagen peptide intake.
  

Individual responses may vary depending on age, lifestyle, and overall nutrition.

QYRA contains collagen peptides derived from bovine hide sources.

These peptides include Type I and Type III collagen, the two primary collagen types naturally found in human skin.

• Type I collagen contributes to structural strength
  
• Type III collagen supports skin elasticity and flexibility

Together they help maintain the skin’s dermal matrix, which contributes to firmness and resilience.

The average molecular weight of VERISOL peptides is approximately 2000 Daltons (2 kDa). For comparison, many generic hydrolyzed collagen peptides are typically 3–5 kDa or larger.

Peptide size and structure may influence absorption and bioavailability during digestion.

QYRA contains collagen peptides derived from bovine hide sources.

These peptides are produced using controlled enzymatic processes to generate the specific bioactive peptide structures used in VERISOL®.

VERISOL is manufactured by Gelita AG in Germany, where collagen research, peptide development, quality testing, and production are conducted within the same integrated manufacturing ecosystem.

This vertically integrated system allows the ingredient to be developed, clinically studied, and produced by one of the world’s most specialized collagen manufacturers.